GSK MEA 115666 A multi-center, open-label, long term safety study of mepolizumab in asthmatic subjects whoparticipated in the MEA 112997 trial.

Grants and Contracts Details

StatusFinished
Effective start/end date11/8/12 → 12/18/16

Funding

  • GlaxoSmithKline: $24,596.00